1 / 1

ncprheum0424-pf3

Figure 3 Proposed analogy of the therapeutic mechanisms of IgG anti-RhoD and anti-CD20 monoclonal antibody treatment for immune thrombocytopenic purpura. Taylor RP and Lindorfer MA (2007) Drug Insight: the mechanism of action of rituximab in autoimmune

elkan
Télécharger la présentation

ncprheum0424-pf3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 3 Proposed analogy of the therapeutic mechanisms of IgG anti-RhoD and anti-CD20 monoclonal antibody treatment for immune thrombocytopenic purpura Taylor RP and Lindorfer MA (2007) Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis Nat Clin Pract Rheumatol3:86–95 doi:10.1038/ncprheum0427

More Related